The FDA is advising U.S. healthcare providers and patients to stop using any plastic syringes in their inventories that were made in China, if possible, as it looks into a spate of quality complaints.

The FDA's Center for Devices and Radiological Health published a statement Tuesday that said issues regarding Chinese-made plastic syringes distributed in the U.S. are "more widespread" than ...

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Sharps Technology, Inc., (NASDAQ: “STSS” and “STSSW”), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class ...

The U.S. Food and Drug Administration's Center for Devices and Radiological Health has warned that Chinese-made plastic syringes that are distributed in the U.S. have "more widespread" quality control ...

Signed PO secures first 12 months of syringe product orders against Sharps and Nephron’s five-year, $200 million Syringe Sales Agreement. Current Asset Purchase Agreement closing timeline is on track ...